The cytostatic effects of lovastatin on ACC-MESO-1 cells

Journal of Surgical Research

Volumn 170, Issue 2, 2011, Pages

  Asakura, Keisuke ^a   Izumi, Yotaro ^a   Yamamoto, Michiko ^a   Yamauchi, Yoshikane ^a   Kawai, Kenji ^b   Serizawa, Akihiko ^c   Mizushima, Tomoko ^b   Ohmura, Mitsuyo ^a   Kawamura, Masafumi ^a   Wakui, Masatoshi ^a   Adachi, Takeshi ^d   Nakamura, Masato ^b,e   Suematsu, Makoto ^a   Nomori, Hiroaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c TOKAI UNIVERSITY HOSPITAL   (Japan)

^d Natl DefCollMed   (Japan)

^e TOKAI UNIVERSITY   (Japan)

Author keywords

autophagic changes; mesothelioma; statins

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE; MAMMALIAN TARGET OF RAPAMYCIN; MEVALONATE KINASE; MEVINOLIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C BETA2; RAC1 PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CANCER SIZE; CELL LINE; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; CYTOSTASIS; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MALIGNANT MESOTHELIOMA; METASTASIS; MOUSE; NONHUMAN; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THORACIC CAVITY;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYTOSTATIC AGENTS; DISEASE MODELS, ANIMAL; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LOVASTATIN; MALE; MESOTHELIOMA; MICE; MICE, INBRED NOD; MICE, SCID; NEUROPEPTIDES; PLEURAL NEOPLASMS; PRENYLATION; RAC GTP-BINDING PROTEINS;

EID: 80052790855     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.06.037     Document Type: Article

References (45)

1. S.S. Ramalingam, and C.P. Belani Recent advances in the treatment of malignant pleural mesothelioma J Thorac Oncol 3 2008 1056
2. M.F. Demierre, P.D. Higgins, and S.B. Gruber Statins and cancer prevention Nat Rev Cancer 5 2005 930
3. A. Sassano, and L.C. Platanias Statins in tumor suppression Cancer Lett 260 2008 11
4. J. Kuoppala, A. Lamminpaa, and E. Pukkala Statins and cancer: A systematic review and meta-analysis Eur J Cancer 44 2008 2122
5. C. Riganti, E. Miraglia, and D. Viarisio Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux Cancer Res 65 2005 516
6. C. Riganti, S. Orecchia, and G. Pescarmona Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma Int J Cancer 119 2006 17
7. J.B. Rubins, T. Greatens, and R.A. Kratzke Lovastatin induces apoptosis in malignant mesothelioma cells Am J Respir Crit Care Med 157 1998 1616
8. A. Martirosyan, J.W. Clendening, and C.A. Goard Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: Potential therapeutic relevance BMC Cancer 10 2010 103
9. C.Y. Wang, H.A. Shui, and T.C. Chang In vivo evidence of duality effects for lovastatin in a nude mouse cancer model Int J Cancer 126 2010 578
10. C. Laezza, L. Fiorentino, and S. Pisanti Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state J Mol Med 86 2008 1341
11. M.G. Gutierrez, H.A. Saka, and I. Chinen Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V cholerae Proc Natl Acad Sci U S A 104 2007 1829
12. M.A. Merrell, S. Wakchoure, and P.P. Lehenkari Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells Eur J Pharmacol 570 2007 27
13. J.E. Dunford, M.J. Rogers, and F.H. Ebetino Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases J Bone Miner Res 21 2006 684
14. A. Cordle, J. Koenigsknecht-Talboo, and B. Wilkinson Mechanisms of statin-mediated inhibition of small G-protein function J Biol Chem 280 2005 34202
15. S. Waiczies, I. Bendix, and T. Prozorovski Geranylgeranylation but not GTP loading determines rho migratory function in T cells J Immunol 179 2007 6024
16. M. Higuchi, N. Masuyama, and Y. Fukui Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells Curr Biol 11 2001 1958
17. C. Murga, M. Zohar, and H. Teramoto Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB Oncogene 21 2002 207
18. B. Chaigne-Delalande, G. Anies, and I. Kramer Nonadherent cells switch to a Rac-mediated, SHIP regulated, Akt activation mode for survival Oncogene 27 2008 1876
19. H. Takeuchi, T. Kanzawa, and Y. Kondo Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells Br J Cancer 90 2004 1069
20. H. Aoki, Y. Takada, and S. Kondo Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: Role of Akt and extracellular signal-regulated kinase signaling pathways Mol Pharmacol 72 2007 29
21. S. Sarkar, B. Ravikumar, and R.A. Floto Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies Cell Death Differ 16 2009 46
22. A. Williams, S. Sarkar, and P. Cuddon C. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway Nat Chem Biol 4 2008 295
23. J.P. Seifert, Y. Zhou, and S.N. Hicks Dual activation of phospholipase C-epsilon by Rho and Ras GTPases J Biol Chem 283 2008 29690
24. T.K. Harden, and J. Sondek Regulation of phospholipase C isozymes by ras superfamily GTPases Annu Rev Pharmacol Toxicol 46 2006 355
25. T.K. Harden, S.N. Hicks, and J. Sondek Phospholipase C isozymes as effectors of Ras superfamily GTPases J Lipid Res 50 Suppl 2009 S243
26. D.M. Bourdon, M.R. Wing, and E.B. Edwards Quantification of isozyme-specific activation of phospholipase C-β2 by Rac GTPases and phospholipase C-epsilon by Rho GTPases in an intact cell assay system Methods Enzymol 406 2006 489
27. R. Fukuyama, T. Fujita, and Y. Azuma Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling Biochem Biophys Res Commun 315 2004 636
28. P.A. Konstantinopoulos, M.V. Karamouzis, and A.G. Papavassiliou Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets Nat Rev Drug Discov 6 2007 541
29. D. Martarelli, A. Catalano, and A. Procopio Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis BMC Cancer 6 2006 130
30. R.K. Amaravadi, and C.B. Thompson The roles of therapy-induced autophagy and necrosis in cancer treatment Clin Cancer Res 13 2007 7271
31. K. Singletary, and J. Milner Diet, autophagy, and cancer: A review Cancer Epidemiol Biomarkers Prev 17 2008 1596
32. L. Moretti, E.S. Yang, and K.W. Kim Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy Drug Resist Updat 10 2007 135
33. K. Degenhardt, R. Mathew, and B. Beaudoin Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis Cancer Cell 10 2006 51
34. R. Mathew, V. Karantza-Wadsworth, and E. White Role of autophagy in cancer Nat Rev Cancer 7 2007 961
35. I. Hashimoto, K. Koizumi, and M. Tatematsu Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells Eur J Cancer 44 2008 1022
36. E.A. Collisson, C. Kleer, and M. Wu Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells Mol Cancer Ther 2 2003 941
37. O. Fromigue, Z. Hamidouche, and P.J. Marie Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion J Biol Chem 283 2008 30549
38. T. Kusama, M. Mukai, and M. Tatsuta Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho Int J Oncol 29 2006 217
39. A. Parikh, C. Childress, and K. Deitrick Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells Prostate 70 2010 971
40. K.M. Sane, M. Mynderse, and D.T. Lalonde A novel geranylgeranyl transferase inhibitor in combination with lovastatin inhibits proliferation and induces autophagy in STS-26T MPNST cells J Pharmacol Exp Ther 333 2010 23
41. A.A. Schmitz, E.E. Govek, and B. Bottner Rho GTPases: Signaling, migration, and invasion Exp Cell Res 261 2000 1
42. Y. Gao, J.B. Dickerson, and F. Guo Rational design and characterization of a Rac GTPase-specific small molecule inhibitor Proc Natl Acad Sci USA 101 2004 7618
43. Y.C. Lin, J.H. Lin, and C.W. Chou Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2 Cancer Res 68 2008 2375
44. Y. Shao, Z. Gao, and P.A. Marks Apoptotic and autophagic cell death induced by histone deacetylase inhibitors Proc Natl Acad Sci U S A 101 2004 18030
45. M. Oh, I.K. Choi, and H.J. Kwon Inhibition of histone deacetylase1 induces autophagy Biochem Biophys Res Commun 369 2008 1179